Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy

SIMPLE SUMMARY: Melanoma is one of the top three causes of brain metastases, which is still a poor prognostic factor of overall survival. Novel systemic therapies have changed the prognosis of patients and the place of local intracranial treatment, surgery and/or radiotherapy in this era remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalmasso, Céline, Pagès, Cécile, Chaltiel, Léonor, Sibaud, Vincent, Moyal, Elisabeth, Chira, Ciprian, Sol, Jean Christophe, Latorzeff, Igor, Meyer, Nicolas, Modesto, Anouchka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430519/
https://www.ncbi.nlm.nih.gov/pubmed/34503304
http://dx.doi.org/10.3390/cancers13174493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430519/
https://www.ncbi.nlm.nih.gov/pubmed/34503304
http://dx.doi.org/10.3390/cancers13174493

Ejemplares similares